top of page
AI pixabay huge.jpg

Payers Warm To Prescription Digital Therapeutics But Want Real-World Evidence, Pilot Projects and Al

Otsuka American Pharmaceutical is tracking payer practices and attitudes about digital therapeutics with a series of four surveys.

A survey of 110 payer decision-makers shows grow digital therapeutics for heart-related conditions and diabetes, a shift away from ad-hoc methods of evaluation of the therapeutics and an openness to conducting pilot programs with manufacturers.


bottom of page